Media & Resources

NEW YORK – The International AIDS Vaccine Initiative (IAVI) has received a grant of US$350,000 from GSK to support implementation of the Human Vaccines Project, a new public-private partnership seeking to transform global disease prevention by collaboratively addressing some of the key scientific challenges in vaccine development across diseases. The GSK grant will help to establish…

The International AIDS Vaccine Initiative (IAVI) is pleased to announce that Dr. Moncef Slaoui, Chairman, Vaccines, GSK, has joined its Board of Directors. “Moncef Slaoui brings a wealth of experience in translating promising research into practical vaccines for use throughout the world,” said IAVI President and CEO Margie McGlynn. “His counsel will be crucial to…

Group’s Grant to IAVI Will Support AIDS Vaccine Research in Asia and Globally.

As International AIDS Vaccine Initiative delegates to the AIDS 2014 conference in Melbourne take part in commemorations and tributes to those HIV/AIDS experts who lost their lives on Flight MH17, the entire IAVI global community extends our deepest condolences to the families, friends and colleagues of these six remarkable people: Pim de Kuijer, lobbyist at…

The IAVI community extends our deepest condolences to the families and friends of all those who died in yesterday’s Malaysia Airlines Flight MH17 disaster. While many details remain unconfirmed, we know that at least some of the lives lost were close partners and colleagues in the global fight to end HIV/AIDS, who were continuing to…

Report shows prevention R&D funding falls 4% due to public sector research budget reductions in U.S., Europe.

Breaking New Ground in a Collective Search for Vaccines against Major Killer Diseases

IAVI Congratulates the Rt. Hon the Lord Fowler on His Powerful New Book